Chilmonczyk, Zdzislaw, et al., "Conformational Flexibity of Serotonin1A Receptor Ligands from Crystallographic Data. Updated Model of the Receptor Pharmacophore", Chemical Abstracts 127:234308, vol. 127, No. 17 (1997). |
Dimoglo, A.S. et al., "Study of Structure-Activity Relations in a Series of Buspirone Analogs Using an Electron-Topological Approach", Chemical Abstracts 129: 22916, vol. 129, No. 3 (1998). |
Hays, Sheryl J., "Synthesis of Carbon-14 Labeled CI-926 and CI-927, New Antihypertensives," Chemical Abstracts 108:21844 vol. 108, No. 3 (1988). |
Ishizumi, Kikuo et al., "Synthesis and Anxiolytic Activity of N-substituted Cyclic Imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-Pyrimidinyl)-1-Piperazinyl]Butyl]-2,3-Bicyclo[2.2.1]Heptanedicarboximide (Tandospirone) and Related Compounds", Chem. Pharm., Bull., vol. 39, No. 9 (1991) pp. 2288-2300. |
Khadilkar, B.M. et al., "Synthesis and Pharmacology of Some 2-[3-(4-Aryl-1-Piperaxinyl)-Propyl]-1H-Benz[De]Isoquinolin-1,3(2H)-Diones", Chemical Abstracts 107:198046, vol. 107, No. 21 (1987). |
Khadilkar, B.M., et al., "Synthesis and Hypotensive Activity of Some Succinimide Derivatives", Chemical Abstracts 119:27951, vol. 119, No. 3 (1993). |
Ryan, M.J., et al., "CI-926 (3-[4-[4-(3-Methylphenyl)-1-Piperazinyl]Butyl]2,4-Imidazolinedione):Antihypertensive Profile and Pharmacology", Chemical Abstracts 105:164679, vol. 105, No. 19 (1986). |
Wu, Yao-Hua, et al., "Psychosedative Agents. N-(4-Phenyl-1-Piperazinylalkyl)-Substituted Cyclic Imides", J. Med. Chem., vol. 12 (1969) pp. 876-881. |
Wu, Y. et al. Journal of Medicinal Chemistry 1969, 12, 876-881. |